Kobayashi Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
18,853
19,666
20,056
19,802
22,572
25,304
Depreciation, Depletion & Amortization
2,969
3,096
3,095
2,625
3,519
3,403
Other Funds
-
-
13
-
-
5,854
Funds from Operations
12,520
10,033
16,438
18,366
21,471
22,855
Changes in Working Capital
3,278
3,480
993
2,269
879
2,848
Net Operating Cash Flow
9,242
13,513
15,445
16,097
22,350
20,007
Capital Expenditures
2,875
3,344
3,678
3,485
3,337
Sale of Fixed Assets & Businesses
4,087
67
23
25
3
Purchase/Sale of Investments
27,539
2,838
965
5,448
10,416
Net Investing Cash Flow
26,605
6,959
4,540
519
7,039
Cash Dividends Paid - Total
3,357
3,521
3,552
3,919
4,343
Issuance/Reduction of Debt, Net
371
286
115
41
103
Net Financing Cash Flow
3,729
3,809
5,155
11,922
9,162
Net Change in Cash
20,513
3,576
6,500
2,896
20,364
Free Cash Flow
6,730
10,628
12,345
13,247
19,509
Net Assets from Acquisitions
-
300
-
2,469
-
Other Sources
257
141
362
99
99
Change in Capital Stock
1
2
1,501
7,963
4,716
Exchange Rate Effect
579
831
750
760
137
Other Uses
535
685
282
136
139
About Kobayashi Pharmaceutical Co.
View Profile
